ABCG2 and breast cancer: In conclusion, in-house developed bisulfite PSQ methods were applied to determine the promoter methylation status of ABCB1, ABCC1 and ABCG2 in 19 human cancer cell lines, MDR cell models as well as tumor, tumor-adjacent and tumor-distant tissues from 16 breast cancer patients.